Image de couverture de livre

Distinct lung functional, histological and cell senescence signatures in the single and repetitive bleomycin mouse models of idiopathic pulmonary fibrosis

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Jamal Bousamaki, Emma A. Rørbeck, Asbjørn Graver Petersen, Stefanie H. Korntner, Susanne E. Pors, Elizabeth F. Redente, Denise Oró, Casper Gravesen Salinas, Rebecca Wendelboe Olsen, Ulf Simonsen, Michael Feigh, Henrik H. Hansen
Format:	Artículo Open Access
Publié:	Wiley 2025
Sujets:	Physiological Reports
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Reproducible lung protective effects of a TGFβR1/ALK5 inhibitor in a bleomycin‐induced and spirometry‐confirmed model of IPF in male mice
par: Asbjørn Graver Petersen, et autres
Publié: (2024)

Nintedanib Lacks Efficacy in a Spirometry‐Confirmed and Bleomycin‐Induced Mouse Model of Idiopathic Pulmonary Fibrosis
par: Jamal Bousamaki, et autres
Publié: (2026)

Procyanidin C1 inhibits bleomycin‐induced pulmonary fibrosis in mice by selective clearance of senescent myofibroblasts
par: Min Shao, et autres
Publié: (2024)

Effects of iloprost on bleomycin-induced pulmonary fibrosis in rats compared with methyl-prednisolone
par: Z.A. Aytemur
Publié: (2012)

Forsythiaside A ameliorates bleomycin‐induced pulmonary fibrosis by inhibiting oxidative stress and apoptosis
par: Fan Yang, et autres
Publié: (2024)

Novel therapeutic strategies and drugs for idiopathic pulmonary fibrosis
par: Zezhou Shi, et autres
Publié: (2024)

Extrapleural air secondary to idiopathic pulmonary fibrosis‐related pneumomediastinum
par: Yuichi Nagata, et autres
Publié: (2024)

Correction to “AQX‐1125, small molecule SHIP1 activator inhibits bleomycin‐induced pulmonary fibrosis”
Publié: (2024)

The soluble factor milieu in idiopathic pulmonary fibrosis dysregulates epithelial differentiation
par: Rosa K. Kortekaas, et autres
Publié: (2024)

Plausible role of INPP4A dysregulation in idiopathic pulmonary fibrosis
par: Meghana Arvind, et autres
Publié: (2024)

Not yet known side effects of pirfenidone in the treatment of idiopathic pulmonary fibrosis?
par: S. Campainha
Publié: (2016)

Pulmonary vascular dysfunction without pulmonary hypertension: A distinct phenotype in idiopathic pulmonary fibrosis
par: Steven D. Nathan, et autres
Publié: (2024)

Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 revision
par: John A. Mackintosh, et autres
Publié: (2024)

Natural products for anti-fibrotic therapy in idiopathic pulmonary fibrosis: marine and terrestrial insights.
par: Ma, Meiting, et autres
Publié: (2025)

Using evidence in clinical practice: A dream coming true in idiopathic pulmonary fibrosis
par: G. Sgalla
Publié: (2017)

Clinical impact of a multidisciplinary discussion group on the diagnosis of idiopathic pulmonary fibrosis in Colombia
par: MAURICIO GONZÁLEZ-GARCÍA
Publié: (2022)

Unveiling the role of copper metabolism and STEAP2 in idiopathic pulmonary fibrosis molecular landscape
par: Yajun Wang, et autres
Publié: (2024)

Lichen planus pigmentosus‐like reaction to pirfenidone in a patient with idiopathic pulmonary fibrosis
par: Marijana Vičić, et autres
Publié: (2024)

The mitigating effect of para‐hydroxycinnamic acid in bleomycin‐induced pulmonary fibrosis in mice through targeting oxidative, inflammatory and fibrotic pathways
par: Zeena A. Hussein, et autres
Publié: (2024)

Experimental Provision of Closed Circuit Television at a Danish Public Library.
par: Pors, Bodil
Publié: (1980)

Ginsenoside Rh4 alleviates idiopathic pulmonary fibrosis by enhancing the CXCL9–CXCR3 axis
par: Lei Yao, et autres
Publié: (2024)

The potential lipid biomarker 5‐HETE for acute exacerbation identified by metabolomics in patients with idiopathic pulmonary fibrosis
par: Yichao Zhao, et autres
Publié: (2024)

Cordyceps sinensis ameliorates idiopathic pulmonary fibrosis in mice via inhibiting mitochondrion‐mediated oxidative stress
par: Ying Zhang, et autres
Publié: (2024)

CombOL: a Library for Practical Enumeration and Boltzmann Sampling of Combinatorial Classes
par: Eriksen, Casper Asbjørn, et autres
Publié: (2026)

Evaluating the robustness of deep learning models trained to diagnose idiopathic pulmonary fibrosis using a retrospective study
par: Wenxi Yu, et autres
Publié: (2025)

Ameliorative effects of avocado oil on bleomycin‐induced lung fibrosis and oxidative stress in rats
par: Naoures Ochi, et autres
Publié: (2025)

Impact of surgical lung biopsy on lung function and survival in patients with idiopathic pulmonary fibrosis in a multi‐centre registry cohort
par: Veronica Marcoux, et autres
Publié: (2024)

A novel senolytic drug for pulmonary fibrosis: BTSA1 targets apoptosis of senescent myofibroblasts by activating BAX
par: Mengxia Shen, et autres
Publié: (2024)

Assessment of fitness for bleomycin use and management of bleomycin pulmonary toxicity in patients with classical Hodgkin lymphoma: A British Society for Haematology Good Practice Paper
par: Aisling Barrett, et autres
Publié: (2024)

Information Retrieval, Experimental Models and Statistical Analysis.
par: Pors, Niels Ole
Publié: (2000)

A novel model for predicting prognosis in patients with idiopathic pulmonary fibrosis based on endoplasmic reticulum stress‐related genes
par: Bin Liu, et autres
Publié: (2024)

BCPT 2025 Prizes and Awards
par: Jens Lykkesfeldt, et autres
Publié: (2025)

BCPT 2024 Prizes and Awards
par: Jens Lykkesfeldt, et autres
Publié: (2024)

Effect of early treatment with transcutaneous electrical diaphragmatic stimulation (TEDS) on pulmonary inflammation induced by bleomycin
par: Laisa A. Santos
Publié: (2013)

Innate T‐cell‐derived IL‐17A/F protects from bleomycin‐induced acute lung injury but not bleomycin or adenoviral TGF‐β1‐induced lung fibrosis in mice
par: Marie T. Moog, et autres
Publié: (2024)

Tileable Surfaces
par: Brander, David, et autres
Publié: (2025)

Dual test gas pulmonary diffusing capacity in patients with idiopathic scoliosis 40 years after diagnosis
par: Rie S. Thomsen, et autres
Publié: (2025)

Transglutaminase 2 knockout mice are protected from bleomycin‐induced lung fibrosis with preserved lung function and reduced metabolic derangements
par: Margaret A. T. Freeberg, et autres
Publié: (2024)

Data for paper titled "DDIT4 promotes aberrant differentiation of alveolar epithelial cells by accelerating impaired autophagy in the idiopathic pulmonary fibrosis"
par: Park, Jaehyun
Publié: (2025)

Survey of Columnar Cacti and Carrying Capacity for Nectar‐Feeding Bats on Curaçao
par: Petit, Sophie, et autres
Publié: (1996)